PTPN6 and cancer: To assess the potential responsiveness of PTPN6 to anti-cancer drugs, we evaluated the correlation between PTPN6 expression and drug sensitivity for 252 anti-cancer drugs using the GDSC dataset across 1,074 cancer cell lines.